$25.47
+0.28
(+1.11%)▲
2.98%
Downside
Day's Volatility :4.96%
Upside
2.04%
11.62%
Downside
52 Weeks Volatility :27.69%
Upside
18.18%
Period | Oruka Therapeutics Inc | Index (Russel 2000) |
---|---|---|
3 Months | -38.98% | 0.0% |
6 Months | -31.85% | 0.0% |
1 Year | 3.92% | 0.0% |
3 Years | -27.36% | -20.2% |
Market Capitalization | 888.3M |
Dividend Share | 0.0 |
Dividend Yield | 0.0% |
Wall Street Target Price | 41.25 |
Profit Margin | 0.0% |
Operating Margin TTM | 0.0% |
Return On Assets TTM | 0.0% |
Return On Equity TTM | 0.0% |
Revenue TTM | 0.0 |
Revenue Per Share TTM | 0.0 |
Quarterly Revenue Growth YOY | 0.0% |
Gross Profit TTM | 0.0 |
Diluted Eps TTM | 0.0 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | -1.64 |
EPS Estimate Next Year | -1.38 |
EPS Estimate Current Quarter | 0.0 |
EPS Estimate Next Quarter | 0.0 |
What analysts predicted
Upside of 61.96%
Sell
Neutral
Buy
Oruka Therapeutics Inc is currently in a neutral trading position according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Oruka Therapeutics Inc | -10.0% | -31.85% | 3.92% | -27.36% | -59.0% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Oruka Therapeutics Inc | NA | NA | NA | -1.64 | 0.0 | 0.0 | 0.0 | NA |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Oruka Therapeutics Inc | NA | NA | -59.0% | NA | 0.0% |
Organization | Oruka Therapeutics Inc |
Industry | Miscellaneous |
Generation Income Properties Inc
$25.47
+1.11%
Touchstone Climate Transition Etf
$25.47
+1.11%
Atlas Lithium Corp
$25.47
+1.11%
Flexshares Quality Dividend
$25.47
+1.11%
Blackrock New York Muni Inc
$25.47
+1.11%
Timothy Plan International Etf
$25.47
+1.11%
Alger 35 Etf
$25.47
+1.11%
Aadi Bioscience Inc
$25.47
+1.11%
Goldman Sachs Access Inflati
$25.47
+1.11%